For most of its history, Track & Trace has been treated as a compliance cost. A regulation arrives, a deadline is set, a system gets built to meet it, and the project ends. That model is breaking down, across pharmaceuticals, tobacco, and food alike.

Having spent the last several years inside Track & Trace systems for a global manufacturer, spanning engineering, product ownership, and now IT delivery coordination, I want to lay out what I am seeing change, and why it matters for anyone building or managing these systems.

The market is not slowing down

Market research firms disagree on the exact size of the global market, projections for 2026 range from roughly USD 5.3 billion to USD 10.3 billion, depending on scope and methodology [1][2][3][4]. What they agree on is the trajectory: consistent double-digit annual growth projected well into the 2030s, with pharmaceutical and biotech manufacturers as the largest end-user segment [3].

That growth is not being driven by novelty. It is being driven by regulation that keeps expanding in scope, through three parallel frameworks that, on the surface, look different but solve the same problem.

Three sectors, one underlying logic

Pharma runs on DSCSA in the US and the Falsified Medicines Directive (FMD) in Europe, both requiring a unique identifier on every pack, verified electronically as it moves from manufacturer to pharmacy. Similar frameworks are in force or rolling out across Asia, each with its own numbering and reporting standard, but the same underlying principle.

Tobacco was an early mover on full-chain traceability. The EU Tobacco Products Directive (TPD), in force since 2019, requires a unique identifier and scanning at every movement through the supply chain. The Directive is now under revision: the European Commission launched a call for evidence in May 2026 [4], following an April 2026 evaluation that found the traceability and security requirements had meaningfully strengthened both the internal market and the effectiveness of the EU’s tobacco control framework [5]. A revision proposal covering both the TPD and the Tobacco Advertising Directive is expected by the end of 2026 [6]. The open question is scope: whether new nicotine product categories will be brought under the same traceability rules that cigarettes and roll-your-own tobacco have operated under since 2019.

Food is where the compliance logic is expanding fastest, and where it started from the weakest base. What began as reactive recall management is becoming proactive origin-to-shelf traceability, driven by food safety regulation and growing consumer demand for transparency. Unlike pharma or tobacco, food traceability does not yet have one dominant framework. It remains a patchwork of national and regional rules, though the EU’s expanding digital product passport initiative is likely to change that.

The technology shift underneath the regulation

Two structural changes are reshaping how these systems get built, across all three sectors.

Software is growing faster than hardware. The barcode and scanning hardware layer is maturing. What is growing faster is the software layer: cloud-based serialization platforms, compliance dashboards, and analytics that turn raw scan data into decisions. The differentiator is shifting from “can you print and read a code” to “can you prove compliance, report on demand, and adapt to a new requirement without a multi-year re-platform.”

Traceability is becoming a platform, not a project. The old model treated each regulation as a discrete project: understand the requirement, build the system, go live, move on. That model does not survive an environment where the EU alone is running active revisions across tobacco and pharmaceuticals, while extending digital product passport requirements into new categories. Systems that treat compliance as configuration will absorb the next regulation. Systems that treat it as custom code, built once for one requirement, will not.

What this means for the people running these systems

If you work in Track & Trace, in pharma, tobacco, or food, the job has quietly shifted. It increasingly means answering three harder questions:

  • Can this system absorb a new product category, market, or reporting requirement without a ground-up rebuild?
  • Can we prove, on demand, that a specific batch or pack met the requirements in force at the time it was made?
  • Is compliance readiness something we assess and sign off before go-live, or something we discover after a factory is already producing?

A pharmaceutical company navigating DSCSA aggregation, a tobacco manufacturer preparing for a TPD revision, and a food producer building origin traceability from scratch are all solving a version of the same problem: making a system built for today’s regulation flexible enough for tomorrow’s.

That is the real shift. Track & Trace is no longer a project with an end date. It is infrastructure, and infrastructure has to be governed, not just built.

Sources

  1. MarketsandMarkets, Track and Trace Solutions Market Report 2026-2031.
  2. Straits Research, Track and Trace Solutions Market Report 2026-2034.
  3. Fortune Business Insights, Track and Trace Solution Market Report.
  4. LexisNexis / National Law Review, coverage of EU Commission call for evidence, May 2026.
  5. European Commission, press release on TPD/TAD evaluation, April 2026.
  6. EU Reporter, coverage of expected TPD/TAD revision proposal.
Published 29 September 2026.